PremiumCompany AnnouncementsOxford Biomedica Seeks Block Listing on London Stock Exchange OXB highlights launch of Innovation, Technolgoy Excellence Board Oxford Biomedica Launches Innovation and Technology Excellence Board PremiumCompany AnnouncementsOxford Biomedica Announces 2025 Annual General Meeting Details Oxford BioMedica Sees Stake Increase by Briarwood Chase Management Oxford Biomedica price target raised to 800 GBp from 740 GBp at RBC Capital PremiumThe FlyOxford Biomedica vice chair Stuart Henderson to retire Oxford Biomedica sees FY25 revenue GBP 160M-GBP 170M Oxford BioMedica: Promising Growth and Attractive Valuation Drive Buy Rating